Gratifii Limited (ASX:GTI) has revealed an increase in director Michael Hill's shareholding following a shareholder-approved placement in July 2026. Hill purchased 625,000 fully paid ordinary shares at $0.04 each and received 312,500 free attaching unlisted options as part of the capital raise. This transaction was sanctioned at an Extraordinary General Meeting on 13 July 2026 and finalized on 21 July 2026.
Key Highlights
- ASX-listed technology and digital engagement firm Gratifii Limited (GTI) executed a director shareholding adjustment through a shareholder-approved placement.
- Director Michael Hill acquired 625,000 shares at $0.04 per share, totaling $25,000 in cash consideration.
- Hill received 312,500 unlisted options free of charge on a 1-for-2 attaching basis, exercisable at $0.10 until 20 July 2028.
- The placement was approved under Listing Rule 10.11 at the 13 July 2026 Extraordinary General Meeting, with settlement on 21 July 2026.
- Hill’s direct shareholding stands at 1,018,518 loan funded shares, while indirect holdings via superannuation and family trusts exceed 3.5 million shares.
Capital Raise and Shareholder Approval Details
The share placement to director Michael Hill was part of a broader capital management strategy requiring shareholder approval. Gratifii convened an Extraordinary General Meeting on 13 July 2026 to authorize the issue of securities under Listing Rule 10.11, which governs related party transactions. Resolution 8 granted the board authority to proceed, ensuring shareholder transparency and protection of minority interests.
Shareholders approved the placement on 13 July 2026, with settlement completed eight days later on 21 July 2026. Prior written clearance for the trade was obtained on the settlement date, confirming compliance with ASX Listing Rules and Corporations Act requirements during a closed trading period.
Share and Option Issuance to Michael Hill
Hill subscribed for 625,000 fully paid ordinary shares at $0.04 each, amounting to $25,000. These shares carry standard voting and dividend rights equal to other ordinary shares. Additionally, Hill received 312,500 unlisted options free of charge on a 1-for-2 attaching basis. The options have an exercise price of $0.10 and expire on 20 July 2028, providing a two-year window to convert into ordinary shares. These options are unlisted and designed to align long-term incentives with shareholder value creation.
Expansion of Indirect Holdings Through Trusts
Beyond direct holdings, Hill’s indirect interests increased via two trusts. The Jarumitoti Superannuation Fund held 2,833,331 shares and 480,673 unlisted performance rights before the placement; post-placement, shares rose to 3,458,331 while performance rights remained unchanged. The Jarumito Family Trust maintained 117,095 shares without change. Combined, Hill’s indirect holdings now exceed 3.5 million shares plus performance rights and options, reflecting a strong long-term commitment.
Direct Shareholding and Loan Funded Shares
Hill retains 1,018,518 loan funded shares directly, unchanged by the placement. Loan funded shares involve borrowing to acquire equity, often used in executive remuneration to facilitate participation without immediate cash outlay. This direct holding is separate from the placement and reflects prior equity arrangements.
The mix of direct loan funded shares and indirect trust holdings demonstrates common estate and tax planning strategies, enhancing tax efficiency, asset protection, and succession planning. Overall, Hill’s aggregate stake exceeds 4.6 million shares plus options and performance rights, representing a significant company interest.
Option Terms and Incentive Alignment
The unlisted options have a $0.10 exercise price, 150% above the $0.04 placement price, making them currently out-of-the-money. Hill has until 20 July 2028 to exercise, encouraging performance-driven value creation before options become profitable. Receiving options free of charge is balanced by the premium exercise price, a typical structure to align director incentives with shareholder outcomes and limit dilution to value-accretive scenarios.
Regulatory Compliance and Closed Period Trading Clearance
The transaction occurred during a closed period when director trading is restricted. Gratifii confirmed prior written clearance was granted on 21 July 2026, the settlement date, ensuring compliance with ASX trading rules. This demonstrates the company’s adherence to governance policies and transparent reporting of director dealings during sensitive periods.
Context of Capital Raise and Shareholder Value Implications
Although the total capital raise size was not disclosed, Hill’s participation at $0.04 per share signals the company’s valuation at the time. Shareholder approval under Listing Rule 10.11 suggests materiality of the placement. Attaching options at a premium price incentivize capital providers while maintaining performance hurdles.
Gratifii operates in digital engagement and technology, with no detailed financials provided in this update. The placement likely aims to strengthen the balance sheet or fund corporate initiatives. Further details on raise proceeds and use of funds may be found in other company disclosures.
Impact on Voting Power and Shareholding Concentration
Hill’s aggregate shareholding increased by 625,000 shares to over 4.9 million shares plus options and performance rights. Prior holdings included 1,018,518 direct loan funded shares and approximately 3.35 million indirect shares. The expansion reflects Hill’s increased commitment and confidence in the company’s outlook.
Additional shares acquired through trusts, especially the superannuation fund, indicate a long-term investment approach. The structured, approved placement contrasts with opportunistic on-market accumulation. This increased stake may raise governance considerations, typically managed through board policies and related party transaction frameworks.
Separation of Placement Securities and Performance Rights
The newly acquired shares and options differ from Hill’s existing 480,673 performance rights held indirectly via the Jarumitoti superannuation fund. These performance rights likely form part of a long-term incentive plan with vesting tied to performance milestones, distinct from immediate ownership securities.
This multi-tiered equity incentive structure balances short-term participation through options with long-term performance accountability via rights. The company did not disclose vesting conditions or potential value of performance rights in this update.
Option Exercise Timeline and Potential Dilution
The 312,500 unlisted options are exercisable until 20 July 2028. The update does not specify total options outstanding, so dilution impact cannot be precisely calculated. Exercising all options at $0.10 would require $31,250 in capital. Future director interest notices will disclose any exercises, providing transparency to investors.
The exercise price sets a clear performance benchmark, requiring significant share price appreciation above the $0.04 placement price before options become economically viable. Options expire worthless if unexercised by the expiry date, limiting dilution risk.